IP Verse

Oyster Point Pharma, Inc. V. Apotex, Inc. - 3:23-cv-03860

Explore the details of the Oyster Point Pharma, Inc. V. Apotex, Inc. case under case number 3:23-cv-03860 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
3:23-cv-03860
Filing Date
Jul 19, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
OYSTER POINT PHARMA, INC. -
APOTEX, INC., -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 19, 2023Corporate Disclosure Statement by OYSTER POINT PHARMA, INC. identifying Viatris, Inc. as Corporate Parent.. (MILLER, GREGORY) (Entered: 07/19/2023)PACER Document
Jul 19, 2023COMPLAINT against APOTEX, INC., ( Filing and Admin fee $ 402 receipt number ANJDC-14467800), filed by OYSTER POINT PHARMA, INC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(MILLER, GREGORY) (Entered: 07/19/2023)PACER Document